References
- Wallace MC , PreenD, JeffreyGPet al. The evolving epidemiology of hepatocellular carcinoma: a global perspective. Expert Rev. Gastroenterol. Hepatol.9(6), 765–779 (2015).
- Bray F , FerlayJ, SoerjomataramIet al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68(6), 394–424 (2018).
- Chen W , ZhengR, BaadePDet al. Cancer statistics in China, 2015. CA Cancer J. Clin.66(2), 115–132 (2016).
- Le VQ , NguyenVH, NguyenVHet al. Epidemiological characteristics of advanced hepatocellular carcinoma in the northern region of Vietnam. Cancer Control26(1), 1073274819862793 (2019).
- Benfeitas R , UhlenM, NielsenJet al. New challenges to study heterogeneity in cancer redox metabolism. Front. Cell Dev. Biol.5, 65 (2017).
- Tran HT , AndersonLH, KnightJD. Membrane-binding cooperativity and coinsertion by C2AB tandem domains of synaptotagmins 1 and 7. Biophys. J.116(6), 1025–1036 (2019).
- Wang S , LiY, MaC. Synaptotagmin-1 C2B domain interacts simultaneously with SNAREs and membranes to promote membrane fusion. eLife5, e14211 (2016).
- Cortes J , HidalgoJ, AguileraSet al. Synaptotagmin-1 overexpression under inflammatory conditions affects secretion in salivary glands from Sjogren’s syndrome patients. J. Autoimmun.97, 88–99 (2019).
- Turecek J , RegehrWG. Neuronal regulation of fast synaptotagmin isoforms controls the relative contributions of synchronous and asynchronous release. Neuron101(5), 938–949.e4 (2019).
- Huang C , WalkerEM, DadiPKet al. Synaptotagmin 4 regulates pancreatic beta cell maturation by modulating the Ca(2+) sensitivity of insulin secretion vesicles. Dev. Cell45(3), 347–361.e5 (2018).
- Park J , ParkSJ, KimS. Inositol polyphosphate multikinase deficiency leads to aberrant induction of synaptotagmin-2 in the forebrain. Mol. Brain12(1), 58 (2019).
- Duran E , MontesMA, JemalIet al. Synaptotagmin-7 controls the size of the reserve and resting pools of synaptic vesicles in hippocampal neurons. Cell Calcium74, 53–60 (2018).
- MacDougall DD , LinZ, ChonNLet al. The high-affinity calcium sensor synaptotagmin-7 serves multiple roles in regulated exocytosis. J. Gen. Physiol.150(6), 783–807 (2018).
- Dolai S , XieL, ZhuDet al. Synaptotagmin-7 functions to replenish insulin granules for exocytosis in human islet beta-cells. Diabetes65(7), 1962–1976 (2016).
- Svec D , TichopadA, NovosadovaVet al. How good is a PCR efficiency estimate: recommendations for precise and robust qPCR efficiency assessments. Biomol. Detect. Quantif.3, 9–16 (2015).
- Zhang W , LuoE, GanJet al. Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound. World J. Surg. Oncol.15(1), 122 (2017).
- Zhang X , LiC, WenTet al. Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern. Eur. J. Gastroenterol. Hepatol.27(8), 933–940 (2015).
- Heimbach JK , KulikLM, FinnRSet al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology67(1), 358–380 (2018).
- Pang Q , ZhouL, QuKet al. Validation of inflammation-based prognostic models in patients with hepatitis B-associated hepatocellular carcinoma: a retrospective observational study. Eur. J. Gastroenterol. Hepatol.30(1), 60–70 (2018).
- Ji F , LiangY, FuSet al. Prognostic value of combined preoperative prognostic nutritional index and body mass index in HCC after hepatectomy. HPB (Oxford)19(8), 695–705 (2017).
- Chen DH , WuQW, LiXDet al. SYPL1 overexpression predicts poor prognosis of hepatocellular carcinoma and associates with epithelial-mesenchymal transition. Oncol. Rep.38(3), 1533–1542 (2017).
- Peng X , MooreM, MathurAet al. Plexin C1 deficiency permits synaptotagmin 7-mediated macrophage migration and enhances mammalian lung fibrosis. FASEB J.30(12), 4056–4070 (2016).
- Xiao B , LiJ, FanYet al. Downregulation of SYT7 inhibits glioblastoma growth by promoting cellular apoptosis. Mol. Med. Rep.16(6), 9017–9022 (2017).
- Kanda M , TanakaH, ShimizuDet al. SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells. Oncogene37(39), 5355–5366 (2018).
- Wang K , XiaoH, ZhangJet al. Synaptotagmin7 is overexpressed in colorectal cancer and regulates colorectal cancer cell proliferation. J. Cancer9(13), 2349–2356 (2018).
- Fei Z , GaoW, XieRet al. Synaptotagmin-7, a binding protein of P53, inhibits the senescence and promotes the tumorigenicity of lung cancer cells. Biosci. Rep.39(2), BSR20181298 (2019).
- Jin H , XuG, ZhangQet al. Synaptotagmin-7 is overexpressed in hepatocellular carcinoma and regulates hepatocellular carcinoma cell proliferation via Chk1-p53 signaling. Onco Targets Ther.10, 4283–4293 (2017).
- Zhang B , ZhangB, ZhangZet al. 42,573 cases of hepatectomy in China: a multicenter retrospective investigation. Sci. China Life Sci.61(6), 660–670 (2018).